Info
Significant Ownership

Significant Ownership of Foresite Capital Fund VI LP

Signature - Title: /s/ James B. Tananbaum - James Tananbaum, Managing Member of the General Partner
Location: Larkspur, CA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Foresite Capital Fund VI LP.

Notify me when Foresite Capital Fund VI LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Foresite Capital Fund VI LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ALMS	Alumis Inc.	Common Stock	14%	$158,014,106	+$9,680,555	16,189,804	+6.5%	James B. Tananbaum	08 Jan 2026
RAPT	RAPT Therapeutics, Inc.	Common Stock	9.3%	$10,875,000		12,500,000		Foresite Capital Fund VI, L.P.	23 Dec 2024
VSTM	Verastem, Inc.	Common Stock	5.1%	$27,693,456		3,135,120		Foresite Capital Fund VI LP	16 Oct 2025
ENGN	enGene Holdings, Inc.	Common Shares, no par value	0%	$0		0		Foresite Capital Fund VI, L.P.	30 Sep 2024
CASI	CASI Pharmaceuticals, Inc.	Ordinary Shares, par value $0.0001	0%	$0	-$1,019,154	0	-100%	Foresite Capital Fund VI LP	31 Dec 2025

Schedules 13D/G Reported by Foresite Capital Fund VI LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.